Skip to main content

Is there a specific age range for which Exondys 51 will work?

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 23, 2023.

Official answer

by Drugs.com

There is currently no specific age range specified for using Exondys 51, but a two-part Phase 3 study scheduled to run until 2026 has recruited boys and young men aged 4 though 21 who meet the study criteria. Previous studies have only investigated boys up to age 19 years. Symptoms of Duchenne muscular dystrophy (DMD) usually appear between 3 and 5 years of age and the condition primarily affects boys at a rate of about 1 in every 3,600 male infants born. If you have an older child, the best thing you can do is talk to your doctor about Exondys 51 treatment.

References
  • Madesen A. Top 5 FAQs: Eteplirsen (Exondys 51) for DMD Treatment Sept 2016. MDA News. https://strongly.mda.org/eteplirsen-exondys-51-dmd-treatment-top-5-frequently-asked-questions/
  • Exondys 51. Sarepta https://www.exondys51.com/faqs

Read next

The new drugs approved by the FDA for the treatment of Duchenne Muscular Dystrophy (DMD) are Amondys 45, Viltepso, Vyondys 53, Exondys 51, Elevidys, Emflaza and Duvyzat. They include classes such as antisense oligonucleotides, a glucocorticoid, a gene therapy and a histone deacetylase (HDAC) inhibitor. Continue reading

Exondys 51 is not technically gene therapy, but it does treat people with Duchenne muscular dystrophy who have a confirmed genetic mutation in their dystrophin gene which means they are unable to make the protein dystrophin. Dystrophin is needed for muscle repair. Without it, muscle cells become damaged and weakened over time, which can affect voluntary movement, such as walking. Continue reading

Exondys 51 can only be used by patients with DMD who have a confirmed mutation in their dystrophin gene that can be treated by skipping exon 51. This works out to be about 13% of people with DMD. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer